J P Lebourgeois - JoVE Visualize

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Cancer|June 1, 1994

Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot studyD Cherqui, P Piedbois, J Y Pierga, et al.

Cancer|September 1, 1983

Early response to chemotherapy as a prognostic factor in Hodgkin's diseaseM Kuentz, F Reyes, B Brun, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy TreatmentJ P LeBourgeois, C J McKenna, B Coster, et al.

Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Cancer|June 1, 1994

Multimodal adjuvant treatment and liver transplantation for advanced hepatocellular carcinoma. A pilot studyD Cherqui, P Piedbois, J Y Pierga, et al.

Cancer|September 1, 1983

Early response to chemotherapy as a prognostic factor in Hodgkin's diseaseM Kuentz, F Reyes, B Brun, et al.

Clinical Oncology (Royal College of Radiologists (Great Britain))|December 11, 1999

Efficacy of an ondansetron orally disintegrating tablet: a novel oral formulation of this 5-HT(3) receptor antagonist in the treatment of fractionated radiotherapy-induced nausea and emesis. Emesis Study Group for the Ondansetron Orally Disintegrating Tablet in Radiotherapy TreatmentJ P LeBourgeois, C J McKenna, B Coster, et al.

Pageof 2